Search

Anna Pagonakis

Examiner (ID: 6985)

Most Active Art Unit
1628
Art Unit(s)
1614, 4173, 1609, 1628, OPET
Total Applications
1238
Issued Applications
444
Pending Applications
73
Abandoned Applications
723

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5705781 [patent_doc_number] => 20060194829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Therapeutic materials and methods' [patent_app_type] => utility [patent_app_number] => 11/312296 [patent_app_country] => US [patent_app_date] => 2005-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11382 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194829.pdf [firstpage_image] =>[orig_patent_app_number] => 11312296 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/312296
Therapeutic materials and methods Dec 19, 2005 Abandoned
Array ( [id] => 6355495 [patent_doc_number] => 20100022475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'NOVEL TRIAZOLOPYRIMIDINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 11/722232 [patent_app_country] => US [patent_app_date] => 2005-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8687 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022475.pdf [firstpage_image] =>[orig_patent_app_number] => 11722232 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/722232
NOVEL TRIAZOLOPYRIMIDINE DERIVATIVES Dec 19, 2005 Abandoned
Array ( [id] => 5522029 [patent_doc_number] => 20090030010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => '3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents' [patent_app_type] => utility [patent_app_number] => 11/302307 [patent_app_country] => US [patent_app_date] => 2005-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34634 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20090030010.pdf [firstpage_image] =>[orig_patent_app_number] => 11302307 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/302307
3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents Dec 13, 2005 Issued
Array ( [id] => 4921586 [patent_doc_number] => 20080069901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'Therapeutic Agent for Metastatic Cancer and Cancer Metastasis Inhibitor' [patent_app_type] => utility [patent_app_number] => 11/792519 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3099 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20080069901.pdf [firstpage_image] =>[orig_patent_app_number] => 11792519 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/792519
Therapeutic Agent for Metastatic Cancer and Cancer Metastasis Inhibitor Dec 5, 2005 Abandoned
Array ( [id] => 4823487 [patent_doc_number] => 20080227870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Carcinogen Solvents in Reducing the Carcinogen Concentration of Cells' [patent_app_type] => utility [patent_app_number] => 11/720029 [patent_app_country] => US [patent_app_date] => 2005-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2292 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227870.pdf [firstpage_image] =>[orig_patent_app_number] => 11720029 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/720029
Carcinogen Solvents in Reducing the Carcinogen Concentration of Cells Nov 30, 2005 Abandoned
Array ( [id] => 5844410 [patent_doc_number] => 20060122162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Methods of using temozolomide formulation intrathecally in the treatment of cancers' [patent_app_type] => utility [patent_app_number] => 11/290779 [patent_app_country] => US [patent_app_date] => 2005-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3806 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122162.pdf [firstpage_image] =>[orig_patent_app_number] => 11290779 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/290779
Methods of using temozolomide formulation intrathecally in the treatment of cancers Nov 29, 2005 Abandoned
Array ( [id] => 11789493 [patent_doc_number] => 09399030 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-26 [patent_title] => 'Topically applied circulation enhancing agent and skin and hair cosmetic and bath agent containing the same' [patent_app_type] => utility [patent_app_number] => 11/283931 [patent_app_country] => US [patent_app_date] => 2005-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6351 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11283931 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/283931
Topically applied circulation enhancing agent and skin and hair cosmetic and bath agent containing the same Nov 21, 2005 Issued
Array ( [id] => 4873702 [patent_doc_number] => 20080200436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Combination Comprising Zd6474 And An Antiandrogen' [patent_app_type] => utility [patent_app_number] => 11/666762 [patent_app_country] => US [patent_app_date] => 2005-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8524 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200436.pdf [firstpage_image] =>[orig_patent_app_number] => 11666762 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/666762
Combination Comprising Zd6474 And An Antiandrogen Oct 31, 2005 Abandoned
Array ( [id] => 6426018 [patent_doc_number] => 20100168168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands' [patent_app_type] => utility [patent_app_number] => 11/990383 [patent_app_country] => US [patent_app_date] => 2005-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15783 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168168.pdf [firstpage_image] =>[orig_patent_app_number] => 11990383 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/990383
Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands Oct 25, 2005 Issued
Array ( [id] => 5814986 [patent_doc_number] => 20060084666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Combined treatment with radiation and an epidermal growth factor receptor kinase inhibitor' [patent_app_type] => utility [patent_app_number] => 11/251982 [patent_app_country] => US [patent_app_date] => 2005-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16497 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084666.pdf [firstpage_image] =>[orig_patent_app_number] => 11251982 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/251982
Combined treatment with radiation and an epidermal growth factor receptor kinase inhibitor Oct 16, 2005 Abandoned
Array ( [id] => 4916192 [patent_doc_number] => 20080096793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'Class III Slrp for the Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 11/577658 [patent_app_country] => US [patent_app_date] => 2005-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10356 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20080096793.pdf [firstpage_image] =>[orig_patent_app_number] => 11577658 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/577658
Class III Slrp for the Treatment of Cancer Oct 12, 2005 Abandoned
Array ( [id] => 5656495 [patent_doc_number] => 20060142231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'DNA damage repair inhibitors for treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/245735 [patent_app_country] => US [patent_app_date] => 2005-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 17423 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142231.pdf [firstpage_image] =>[orig_patent_app_number] => 11245735 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/245735
DNA damage repair inhibitors for treatment of cancer Oct 5, 2005 Issued
Array ( [id] => 5881504 [patent_doc_number] => 20060030587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Method of treating attention deficit disorders with d-threo methylphenidate' [patent_app_type] => utility [patent_app_number] => 11/244924 [patent_app_country] => US [patent_app_date] => 2005-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2593 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20060030587.pdf [firstpage_image] =>[orig_patent_app_number] => 11244924 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/244924
Method of treating attention deficit disorders with d-threo methylphenidate Oct 5, 2005 Abandoned
Array ( [id] => 4899865 [patent_doc_number] => 20080119479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Combination Comprising Zd6474 And Imatinib' [patent_app_type] => utility [patent_app_number] => 11/663913 [patent_app_country] => US [patent_app_date] => 2005-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7755 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20080119479.pdf [firstpage_image] =>[orig_patent_app_number] => 11663913 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/663913
Combination Comprising Zd6474 And Imatinib Sep 22, 2005 Abandoned
Array ( [id] => 5829156 [patent_doc_number] => 20060063784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Method of using substituted pyrazolo [1,5-a] pyrimidines' [patent_app_type] => utility [patent_app_number] => 11/221846 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44853 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063784.pdf [firstpage_image] =>[orig_patent_app_number] => 11221846 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/221846
Method of using substituted pyrazolo [1,5-a] pyrimidines Sep 8, 2005 Abandoned
Array ( [id] => 112350 [patent_doc_number] => 07718801 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-18 [patent_title] => 'Substituted imidazole derivative' [patent_app_type] => utility [patent_app_number] => 11/661486 [patent_app_country] => US [patent_app_date] => 2005-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 72950 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/718/07718801.pdf [firstpage_image] =>[orig_patent_app_number] => 11661486 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/661486
Substituted imidazole derivative Aug 29, 2005 Issued
Array ( [id] => 4826884 [patent_doc_number] => 20080125428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Cancer Treatment Method' [patent_app_type] => utility [patent_app_number] => 11/574331 [patent_app_country] => US [patent_app_date] => 2005-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7666 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20080125428.pdf [firstpage_image] =>[orig_patent_app_number] => 11574331 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/574331
Cancer Treatment Method Aug 24, 2005 Abandoned
Array ( [id] => 4932439 [patent_doc_number] => 20080003214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-03 [patent_title] => 'Medicaments Comprising Carbonyl Compounds, And The Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/575711 [patent_app_country] => US [patent_app_date] => 2005-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29560 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20080003214.pdf [firstpage_image] =>[orig_patent_app_number] => 11575711 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/575711
Medicaments Comprising Carbonyl Compounds, And The Use Thereof Aug 23, 2005 Abandoned
Array ( [id] => 5672987 [patent_doc_number] => 20060178342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease' [patent_app_type] => utility [patent_app_number] => 11/198663 [patent_app_country] => US [patent_app_date] => 2005-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 24210 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178342.pdf [firstpage_image] =>[orig_patent_app_number] => 11198663 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/198663
Hyaluronan as a chemo-sensitizer in the treatment of cancer Aug 4, 2005 Issued
Array ( [id] => 5015704 [patent_doc_number] => 20070258912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Use of Fluorescent Whitening Agents as Antimicrobials' [patent_app_type] => utility [patent_app_number] => 11/659549 [patent_app_country] => US [patent_app_date] => 2005-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6368 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20070258912.pdf [firstpage_image] =>[orig_patent_app_number] => 11659549 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/659549
Use of Fluorescent Whitening Agents as Antimicrobials Aug 2, 2005 Abandoned
Menu